China MedTripPatient guides ↗

Patient information · Blood cancers

Understanding your
CAR-T journey in China.

A clear guide to specialist assessment, the treatment pathway and the practical arrangements to discuss before you travel.

Prepared by China MedTrip · Sources checked September 22, 2026
General information, not an individual treatment plan.

01 / Understand the treatment

What is CAR-T?

CAR-T is a treatment in which T cells are modified to recognise a target on cancer cells. This guide focuses on treatment made from a patient’s own cells for certain blood cancers. Suitability depends on the diagnosis, previous treatment, overall health and the specific product. [1]

A specialist makes the clinical decision.

An assessment is the first step—not a commitment to treatment. Ask which options fit your situation, whether CAR-T is appropriate now, and what alternatives should be considered.

We help you move the arrangements forward.

China MedTrip helps arrange specialist appointments: we prepare, submit and follow up on requests and help coordinate records, translation, travel and agreed in-person support. Final appointment details and the treatment plan come from the hospital.

02 / From assessment to follow-up

One journey. Several important stages.

This is an overview, not a fixed schedule. Your hospital will explain which stages apply and when they can take place. [1]

  1. Specialist assessment

    The team reviews your diagnosis, treatment history and health, then discusses eligibility, alternatives and further tests.

    Before treatment is agreed
  2. Confirm the clinical and practical plan

    Ask for the proposed product, consent discussion, cost breakdown, collection date and arrangements for a caregiver and local stay.

    Before non-refundable bookings
  3. Collect the T cells

    A procedure called leukapheresis collects cells from your blood for manufacture. The centre gives preparation instructions.

    Hospital-led procedure
  4. Manufacture and check the cells

    The cells are modified and checked. Your specialist decides whether treatment is needed to control the disease while you wait.

    Timing varies by product
  5. Prepare for treatment and infuse

    The team prescribes preparatory treatment and decides when the cells can be infused. Do not change medicines without their advice.

    Clinical readiness comes first
  6. Monitor, recover and follow up

    The hospital monitors side effects and response, then sets discharge, local-stay and follow-up requirements.

    Ongoing care after infusion
How much time should you allow? As a general planning guide, cell manufacture may take approximately 2–3 weeks, although timing varies by product, quality checks and hospital arrangements. Follow the specific timeframe confirmed by your treating hospital at your visit. This is not the full waiting time or the total duration of your stay in China. Ask your treating centre for a written schedule covering assessment, collection, manufacture, monitoring and travel clearance.

03 / Know what is being proposed

What should your plan explain?

Your hospital’s clinical plan

  • Why the proposed treatment fits your diagnosis and prior therapies.
  • The product, expected benefits, uncertainties and individual risks.
  • Whether it is approved treatment for your condition or a clinical trial.
  • Monitoring, possible additional treatment and follow-up arrangements.

Your practical support plan

  • Confirmed appointment, department and hospital location.
  • Requested records and translation requirements.
  • Agreed interpreting, accompaniment, transport and accommodation support.
  • Your coordinator’s contact details and a plan for schedule changes.
A China MedTrip Care Plan covers practical coordination. It is separate from the medical treatment plan prepared by your clinicians.
Benefits and risks both matter. CAR-T can produce lasting responses in some patients, but does not work for everyone. Serious and potentially life-threatening side effects can occur, including cytokine release syndrome, neurological problems and infections. Discuss your personal risks with the specialist. For urgent symptoms, contact the treating team or emergency services—not a travel coordinator. [1]

04 / Bring useful questions, not assumptions

Your preparation checklist.

Ask the hospital what to prepare

  • Diagnosis and pathology reports.
  • Previous treatments, dates and responses.
  • Recent reports and imaging, in the required format.
  • Current medicines and relevant health history.
  • Required translations and the agreed way to share records.

Confirm before booking travel

  • Hospital acceptance and appointment details.
  • Itemised medical estimate and payment terms.
  • What happens if manufacture fails or treatment cannot proceed.
  • Caregiver, accommodation and local-stay requirements.
  • Hospital emergency contact and your accompaniment contact.
Open the travel checklist →

Keep your first enquiry brief. Do not send full medical records, passport copies or scans through public comments or the initial enquiry form. Agree on consent and a suitable sharing method first.

05 / Common patient questions

Questions worth asking early.

Can you help me book a specialist appointment?

Yes. We help prepare, submit and follow up on your appointment request and coordinate practical requirements with the hospital. We work towards arranging an appropriate face-to-face consultation; the hospital confirms the doctor, date and acceptance. An assessment does not automatically mean you will receive CAR-T.

Is cell manufacture the whole waiting time?

No. Record review, tests, collection slots, manufacturing, quality checks and readiness for infusion are separate steps. Ask for your own expected timeline rather than relying on a general estimate.

Is a “per-infusion” price the total cost?

Not necessarily. Request a written breakdown for assessment, collection, the cell product, other medicines, hospital care, complications and follow-up. Confirm exclusions, deposits and cancellation terms. China MedTrip coordination fees and travel expenses should be listed separately.

Is a clinical trial the same as approved treatment?

No. Trials have their own eligibility rules, consent process and uncertainties. Ask the hospital to explain the study, oversight, costs and alternatives. A trial is not a guaranteed place or a guaranteed lower-cost treatment.

Can I fly home immediately after infusion?

Do not assume that you can. Monitoring and proximity to the treatment centre remain important after infusion. The treating team must confirm discharge and travel arrangements for your circumstances; requirements differ by product and centre. [2]

Does CAR-T guarantee a cure?

No. Results vary by disease, product and individual circumstances. Ask the specialist what the evidence means for you, how response will be assessed and what options remain if treatment does not work. [1]

Sources & editorial notes

Information you can check.

This guide provides general patient information and practical planning questions. It does not replace an individual assessment or treatment plan from your clinical team.

  1. US National Cancer Institute — CAR T Cells: Engineering Patients’ Immune Cells to Treat Their Cancers. General background, benefits and risks; updated February 26, 2025.
  2. US FDA — CAR-T safety and monitoring update, 2025. Supports the need for post-infusion monitoring; US label requirements are not presented as Chinese hospital rules.

Prepared by China MedTrip · Sources checked September 22, 2026 · Editorial policy. No independent clinician review is claimed. Your hospital’s current guidance takes precedence.

Your next step

Let’s help arrange the assessment.

Tell us your preferred city, timeframe and practical support needs. We can help move the appointment process forward and clarify what the hospital needs next.

Request a Care Plan →

Practical coordination—not a treatment recommendation or emergency service.

© 2026 China MedTrip · Independent, non-clinical patient coordination.
[email protected] · Editorial policy